Hybrid Predictive Machine Learning and Deep Neural Network Ensemble for Early-Stage Cardiovascular Disease Risk Assessment and Prognosis
DOI:
https://doi.org/10.64149/J.Carcinog.24.9s.222-232Keywords:
Cardiovascular Disease, Machine Learning, Deep Neural Network, Internet of Medical Things (IoMT), Ensemble Learning.Abstract
This study introduces an intelligent framework that integrates machine learning and deep neural network ensemble techniques for early detection and prognosis of cardiovascular diseases. The system utilizes real-time physiological data collected from Internet of Medical Things (IoMT) devices, including ECG sensors, heart rate monitors, and blood pressure trackers. To ensure the accuracy and reliability of input data, preprocessing steps such as noise reduction, normalization, and missing value imputation are employed. The most significant health indicators are identified through effective feature selection methods and then processed using optimized classifiers such as Support Vector Machines (SVM), Random Forests, and eXtreme Gradient Boosting (XGBoost), which are combined in an ensemble architecture to improve diagnostic precision. The framework demonstrates remarkable performance in predicting cardiovascular disease risk, achieving higher accuracy, reduced false positives, and enhanced consistency compared to conventional methods. It is designed on a cloud-based infrastructure that ensures scalability and real-time processing for continuous patient monitoring. Experimental evaluation on real-world cardiovascular datasets confirms the framework’s efficiency in early-stage risk assessment and clinical decision support. The results highlight the potential of combining traditional machine learning and deep learning paradigms to achieve proactive healthcare management and improve patient outcomes.




